Product

Sacubitril and Valsartan Tablets

Aliases

Sacubitril and Valsartan Tablets 49mg/51mg

2 clinical trials

2 indications

Indication

Bioequivalence Study

Indication

Chronic Heart Failure

Clinical trial

A Bioequivalence Study of Two Formulations of Sacubitril/Valsartan 49 mg/51 mg Film-coated Tablets in Healthy Thai Subjects Under Fasting Conditions

Status: Not yet recruiting, Estimated PCD: 2024-05-01

Clinical trial

A Bioequivalence Study of Two Formulations of Sacubitril/Valsartan 97 mg/103 mg Film-coated Tablets in Healthy Thai Subjects Under Fasting Conditions

Status: Not yet recruiting, Estimated PCD: 2024-04-01